Literature DB >> 1396026

Estrogen and progesterone receptors in cytology: a comprehensive review.

S Masood1.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1396026     DOI: 10.1002/dc.2840080508

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


× No keyword cloud information.
  17 in total

1.  Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.

Authors:  B Kocatürk; C Tieken; D Vreeken; B Ünlü; C C Engels; E M de Kruijf; P J Kuppen; P H Reitsma; V Y Bogdanov; H H Versteeg
Journal:  J Thromb Haemost       Date:  2015-07-31       Impact factor: 5.824

2.  Identification of an estrogen-regulated circadian mechanism necessary for breast acinar morphogenesis.

Authors:  Stefano Rossetti; Francesca Corlazzoli; Alex Gregorski; Nurul Hidayah A Azmi; Nicoletta Sacchi
Journal:  Cell Cycle       Date:  2012-08-30       Impact factor: 4.534

Review 3.  The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?

Authors:  Natalie B Aquino; Mary B Sevigny; Jackielyn Sabangan; Maggie C Louie
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2012       Impact factor: 3.781

4.  Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor-Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis.

Authors:  Taylor E Escher; Asona J Lui; Eric S Geanes; Katherine R Walter; Ossama Tawfik; Christy R Hagan; Joan Lewis-Wambi
Journal:  Mol Cancer Res       Date:  2019-01-17       Impact factor: 5.852

5.  Upregulation of CYP1B1 by hypoxia is mediated by ERα activation in breast cancer cells.

Authors:  Jin Young Min; Gi Ho Lee; Tilak Khanal; Sun Woo Jin; Sang-Yeop Lee; Hyung Gyun Kim; Ju-Yong Hyon; Young-Ho Chung; Sang Keun Ha; Eun Hee Han; Hye Gwang Jeong
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

6.  p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers.

Authors:  Anny Shai; Henry C Pitot; Paul F Lambert
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

7.  Mouse models of estrogen receptor-positive breast cancer.

Authors:  Shakur Mohibi; Sameer Mirza; Hamid Band; Vimla Band
Journal:  J Carcinog       Date:  2011-12-22

Review 8.  Estrogen receptor transcription and transactivation: Basic aspects of estrogen action.

Authors:  S Nilsson; J A Gustafsson
Journal:  Breast Cancer Res       Date:  2000-07-13       Impact factor: 6.466

9.  Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.

Authors:  Xiaoqing Jia; Qi Hong; Li Lei; Daqiang Li; Jianwei Li; Miao Mo; Yujie Wang; Zhimin Shao; Zhenzhou Shen; Jingyi Cheng; Guangyu Liu
Journal:  Oncotarget       Date:  2015-04-20

10.  Mapping ERβ genomic binding sites reveals unique genomic features and identifies EBF1 as an ERβ interactor.

Authors:  Thien P Le; Miao Sun; Xin Luo; W Lee Kraus; Geoffrey L Greene
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.